Presenting: EerDx – Transforming Sleep Diagnostics with Ease

EerDx – Co-Founder and CEO Bart Emery presenting, is bringing clinical-grade sleep diagnostics to a comfortable, patient-friendly earbud format.

There are 50+ Million Americans with diagnosable and treatable sleep disorders… but 45 Million are undiagnosed! The CDC has cited sleep as a public health academic, and the cost of undiagnosed sleep disorders is over $150B per year. Yet there are only 1.5 Million sleep studies performed per year due to a lack of specialized physicians, as well as the lab-based locations and inconvenience of trying to get end patients to use clunky home diagnostic equipment. EerDx eliminates these barriers with a revolutionary earbud-based solution that provides accurate, clinical-grade data in a patient-friendly, accessible format. By making sleep studies accessible for everyone from home, EerDx is redefining how we approach treating sleep conditions.

Our target markets are the 8,000 existing sleep medicine providers and emerging telehealth platforms who need a simpler, more comfortable diagnostic solution and are reimbursed under the existing set of diagnostic codes. These providers would also like to move more low complexity patients from non-profitable in-lab to home sleep tests and just focus on serving the highest complexity and paying patients in the sleep lab, but the current technology is not accurate enough. We serve as a funnel for these high value patients.

Our competition are other FDA-cleared home sleep testing solutions, and our advantage is our focus on combining novel electrodes with higher accuracy particularly in brain waves (EEG) with unmatched patient comfort in an innovative earbud format, all delivered in a patient and physician-friendly package.

The total US market size for the new field of home sleep testing is $300M, however if every recommended patient received evaluation it would surpass $6B. Tailwinds include the recent approval of high-cost obesity drugs for sleep apnea, driving patient and physician interest and demanding better home diagnostics.

Top 3 Challenges:

• Understanding how to stage development with clinical research and funding.
• Understanding our unit economics and how to reduce over time.
• Securing adequate funding.

Our PitchBoulder Ask: If you were a med device VC, what questions would you have? What are the gaps in the presentation that would make it stronger?